<DOC>
	<DOCNO>NCT01956448</DOCNO>
	<brief_summary>To perform randomized comparison BioMatrix Flex™ Resolute Integrity® stent treatment unselected patient ischemic heart disease .</brief_summary>
	<brief_title>SORT-OUT VI - Randomized Clinical Comparison Biomatrix Flex® Resolute Integrity®</brief_title>
	<detailed_description>SORT OUT VI randomize , multicenter , all-comer , two-arm , non-inferiority trial compare Biolimus-eluting Biomatrix Flex Zotarolimus-eluting Medtronic Resolute Integrity treatment atherosclerotic coronary artery lesion . Primary Endpoint : Target lesion failure within 12 month stent implantation ( combination cardiac death , myocardial infarction ( index procedure relate ) relate index lesion target lesion revascularization ) . Secondary Endpoints : Individual component primary end point comprise secondary end point stent thrombosis rate accord Academic Research Consortium definition ( see protocol specification secondary endpoint ) . Clinically driven event detection use avoid study-induced reinterventions . Data mortality , hospital admission , coronary angiography , repeat percutaneous coronary intervention , coronary bypass surgery obtain randomly allocate patient follow national Danish administrative healthcare registry : Civil Registration System ; Western Denmark Heart Registry ; Danish National Registry Patients , maintain record hospitalization Denmark ; Danish Registry Causes Death</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Patients age 18 year chronic stable coronary artery disease acute coronary syndrome , least one coronary artery lesion 50 % diameter stenosis , require treatment drugeluting stent . life expectancy le one year allergy aspirin , clopidogrel , ticagrelor , prasugrel , sirolimus , biolimus participation another randomize trial inability provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>DES</keyword>
	<keyword>Angina pectoris</keyword>
	<keyword>Stent</keyword>
</DOC>